The Scientific Committee of the Fondation Jérôme Lejeune is composed of 23 independent experts who help us in the evaluation and selection of the research projects submitted through our calls

Jean-Louis Guéant, MD, Ph.D, PU-PH, Research Director INSERM
President of the Scientific Committee of the Fondation Jérôme Lejeune Nutrition, Génétique et Exposition aux risques Environnementaux (NGERE), Université de Lorraine, Vandoeuvre-les-Nancy, France

Yann Hérault, Ph.D, Research Director CNRS
Honorary chair Scientific Committee of the Fondation Jérôme Lejeune
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg & Institut Clinique de la Souris (ICS) Illkirch, France

Marie-Claude Potier, PharmD, Ph.D, Research Director CNRS
Honorary chair Scientific Committee of the Fondation Jérôme Lejeune
Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpêtrière, Paris, France

Paul Bastard, MD, Ph.D
Institut Imagine (Université de Paris, INSERM, AP-HP), Paris, France

Eugenio Barone, Prof., Ph.D
Sapienza University of Rome, Faculty of Medicine, Roma, Italy

Jacques S. Beckmann, Prof., Ph.D
Honorary Professor Université de Lausanne (UNIL), Lausanne, Switzerland

Cécile Cieuta-Walti, MD
Institut Jérôme Lejeune, Paris, France
University of Sherbrooke, Québec, Canada

Aurore Curie, MD, Ph.D, MCU-PH
Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Institut des Sciences Cognitives Marc Jeannerod, Bron, France

Alain D. Dekker, Ph.D
Head of the department of practice-oriented scientific research of Alliade Care Group, Beetsterzwaag, & University Medical Center Groningen, The Netherlands

Juan Fortea Ormaechea, MD, Ph.D
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Mario Gomes-Pereira, Ph.D, Research Director DR2 INSERM
Institut de Myologie, Sorbonne Université, Paris, France

Faycal Guedj, Ph.D
National Institutes of Health (NIH), Bethesda, Maryland, United States

Julien Laffaire, Ph.D
Biostatistics manager, Pharnext, Paris, France

Fréderic Laumonnier, Ph.D, Research Director INSERM
Faculté de Médicine, Université de Tours, France

Thomas Lecuit, Prof., Ph.D
Institut de Biologie du Développement de Marseille (IBDM), France, & Collège de France, Paris

Patrícia Maciel, Ph.D
University of Minho, School of Medicine, Porto, Portugal

Silvia de Marchis, Ph.D
University of Turin, Life Sciences and Systems Biology, Torino, Italy

Eimear McGlinchey, Ph.D, Assistant Professor in Intellectual Disability in the School of Nursing & Midwifery
Trinity Centre for Ageing and Intellectual Disability, Trinity College Dublin, Ireland

Massimo Mantegazza, Ph.D, Research Director DR2 INSERM
Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

Andre Mégarbané, MD, Ph.D
Institut Jérôme Lejeune, CRB BioJeL, Paris, France

Clotilde Mircher, MD
Institut Jérôme Lejeune, Paris, France

Hervé Moine, Ph.D, Research Director CNRS
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France

Juan Narbona Garcia, MD
Clinica Universitária de Navarra, Pamplona, Spain

Andrés Ozaita, Prof., Ph.D
University of Pompeu Fabra, Department of Medicine and Life Sciences, Barcelona, Spain

Florence Rage, Ph.D, DR2 CNRS, Research in Molecular Biology
Institut de Génétique Moléculaire, Montpellier, France

Daniel Satgé, MD
ONCODEFI and Institut Universitaire de Recherche Clinique, Montpellier, France

Margarida Saraiva, Ph.D, Group leader, Immune Regulation
I3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal

Frances Wiseman, Ph.D
University of College London (UCL), Group Leader and Programme Leader for Animal Models, London, United Kingdom

Binnaz Yalçin, Ph.D, Dr Inserm
Institut NeuroMyoGène, Université de Lyon, Claude Bernard Lyon 1, France

 

2026.08.20